NCT02253004View on ClinicalTrials.gov

Induction of Migraine Aura With Cilostazol

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Migraine With AuraStroke
Interventions
DRUG

Cilostazol

Single oral administration of active or placebo one week apart

DRUG

Placebo

Trial Locations (1)

2730

Herlev Hospital, Dept Neurology, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02253004 - Induction of Migraine Aura With Cilostazol | Biotech Hunter | Biotech Hunter